Nurix Therapeutics, Inc. NRIX Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s other operating expenses?
- Nurix Therapeutics, Inc. (NRIX) reported other operating expenses of $98.75M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s other operating expenses changed year-over-year?
- Nurix Therapeutics, Inc.'s other operating expenses increased by 21.4% year-over-year, from $81.32M to $98.75M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s other operating expenses has grown at a 25.8% compound annual growth rate (CAGR), from $147.64M to $369.65M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.